Quarterly report pursuant to Section 13 or 15(d)

Organization and Description of Business - Additional Information (Detail)

v2.4.0.8
Organization and Description of Business - Additional Information (Detail) (USD $)
3 Months Ended 6 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2014
Jun. 30, 2013
Dec. 31, 2013
Jun. 30, 2014
Stock Option [Member]
Jun. 30, 2014
Argus Neurooptics LLC [Member]
Mar. 17, 2014
Argus Neurooptics LLC [Member]
Jun. 30, 2014
Nuro Pharma, Inc [Member]
Bridge Loan [Member]
Mar. 17, 2014
Nuro Pharma, Inc [Member]
Bridge Loan [Member]
Organization And Nature Of Business [Line Items]                  
Equity Method Investment Ownership Percentage             35.00%    
Financing Receivable, Recorded Investment, Current                 $ 50,000
Loans Receivable Interest Rate               8.00%  
Long-term Investments, Total 250,000 250,000   0   250,000 250,000    
Payments to Acquire Short-term Investments   $ 295,000 $ 0   $ 243,000        
Investment Options, Expiration Date Sep. 30, 2014 Sep. 30, 2014